Business Type:Lab/Research institutions
Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Lab/Research institutions
Tel: 86-21-58550039;86-21-31268550-8004
Mobile:
Tel: 86-21-58550039;86-21-31268550-8004
Fax: 86-21-50790419
Province/state: shanghai
City: shanghai
Street: Suite B-10#, 6999 Chuansha Road, Pudong District, Shanghai 201202, China
MaxCard:
CAS NO.361442-04-8
high quality /low price Saxagliptin good supplier
Naphazoline hydrochloride is the hydrochloride form of Naphazoline. It is a sympathomimetic agent having strong alpha adrenergic activity. It targets on the alpha-receptors in the arterioles of the conjunctiva, activating the adrenal system to produce systemic vasoconstriction. This leads to a decrease in blood flow in the nasal passages, further causing decreased congestion. It is contained in many over-the-counter eye drops.
Saxagliptin is a potent and selective reversible inhibitor of dipeptidyl peptidase-4, which is being developed for the treatment of type 2 diabetes. It is absorbed rapidly after oral administration an d has a pharmacokinetic profile compatible with once daily dosing.
Shacketine is a type 2 diabetes drug that can stimulate the pancreas to produce more insulin after the meal. It was reached by the cooperation of AstraZeneca and Bristol-Myers Squibb Company and belongs to DPP-IV inhibitor. It plays the role through inhibiting GLP-l degradation. GLP-I is the hormones naturally produced in the intestine after taking food. It can regulate the secretion of insulin and strengthen the utilization of glucose in the peripheral tissues. The single medication of Shacketine can improve blood glucose control and the combined medication of Shacketine with metformin, sulfonylurea and thiazolidinediones can enhance curative effect. It leads to low risk of hypoglycemia and its adverse reactions are similar to placebo, showing better tolerance.
On July 31, 2009, Shakleitine tablets (Onglyza), a new drug of type 2 diabetes, jointly researched and developed AstraZeneca and Bristol-Myers Squibb was approved by the US FDA. It can be taken once a day to treat type 2 diabetes combined with controlling Diet and exercise. The most common side effects are upper respiratory tract infections, urinary tract infections and headaches. And other side effects include allergic reactions, such as rash and urticaria.
Structure | |
Catalog No. | QE-2738 |
Name | Saxagliptin |
Alt. name | |
CAS number | 361442-04-8 |
Related CAS | |
MFCD number | MFCD12756398 |
Purity | 95% |
Formula | C18H25N3O2 |
FW | 315.4 |
Note | |
Storage | Refrigerated |
Shipping | Normal |